Skip to main content
Clinical Trials/NCT04985864
NCT04985864CompletedNot Applicable

A Study on Effect of Simultaneous Application of Transcranial Direct Current Stimulation (tDCS) and Robotic Gait Training on Gait Function in Stroke Patients With Gait Impairment

Yun-Hee Kim1 site in 1 country24 target enrollmentStarted: August 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
1
Primary Endpoint
Change in 10 meter walk test

Study Overview

Brief Summary

The purpose of this study was to investigate the effects of simultaneous application of transcranial direct current stimulation (tDCS) with robotic gait training in stroke patients with gait impairment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
19 Years to 79 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age: 19 - 79 years
  • •More than 3 months post stroke
  • •Functional ambulation classification (FAC) (1~4)

Exclusion Criteria

  • •History of serious neurological disease other than stroke
  • •Difficult to understand experimental tasks because of extremely severe cognitive impairment (Korean-Mini-Mental State Examination, K-MMSE≤10)
  • •History of psychiatric disease
  • •Contraindicated to tDCS

Arms & Interventions

Robot gait training with brain stimulation

Experimental

Lokomat robot training and anodal transcranial direct current stimulation (tDCS) on the leg motor areas

Intervention: Brain stimulation (Device)

Robot gait training with brain stimulation

Experimental

Lokomat robot training and anodal transcranial direct current stimulation (tDCS) on the leg motor areas

Intervention: Treadmill gait training (Device)

Gait training with sham brain stimulation

Active Comparator

Treadmill gait training and anodal sham transcranial direct current stimulation (tDCS) on the leg motor areas

Intervention: Treadmill gait training (Device)

Outcomes

Primary Outcomes

Change in 10 meter walk test

Time Frame: session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up)

Measurement of the time it takes a subject to walk 10m with self selected gait speed. To perform the test, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: "Please walk this distance at your normal pace when I say go."

Secondary Outcomes

  • Change in Timed Up and Go test (TUG)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Changes in motor evoked potential(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Geriatric Depression Scale (GDS)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Fugl-Meyer Assessment(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Functional ambulatory category(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Modified Ashworth Scale(MAS)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Changes in Brain activation of resting-state functional MRI(session 0 (initial visit); session 10 (at approximately 4 weeks))
  • Change in Berg Balance Scale (BBS)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Muscle Manual Test (MMT)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Modified Bathel index (MBI)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))
  • Change in Range of Motion (ROM)(session 0 (initial visit); session 10 (at approximately 4 weeks); after 4 weeks from intervention termination (follow-up))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Yun-Hee Kim

Professor

Samsung Medical Center

Study Sites (1)

Loading locations...

Similar Trials